Screening of Syphilis Using Rapid Plasma Reagin Test in Apparently Healthy Population in Madhya Pradesh: a 6 Years Study
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Catalase Test: Lab-3380
Standard Operating Procedure Subject Catalase Test Index Number Lab-3380 Section Laboratory Subsection Microbiology Category Departmental Contact Sarah Stoner Last Revised 9/18/2019 References Required document for Laboratory Accreditation by the College of American Pathologists (CAP), Centers for Medicare and Medicaid Services (CMS) and/or COLA. Applicable To Employees of Gundersen Health System Laboratory, Gundersen Tri-County, Gundersen St. Joseph, Gundersen Boscobel Hospital, and Gundersen Palmer Lutheran Hospital Laboratories. Detail PRINCIPLE: The breakdown of hydrogen peroxide into oxygen and water is mediated by the enzyme catalase. When a small amount of an organism that produces catalase is introduced into hydrogen peroxide, rapid elaboration of bubbles of oxygen, the gaseous product of the enzyme’s activity, is produced. CLINICAL SIGNIFICANCE: This test is used as an aid in distinguishing between Staphylococci and Streptococci. All members of the genus Staphylococcus are catalase (+), where as members of the genus Streptococcus are catalase (-). Listeria monocytogenes {catalase (+)} can be distinguished from beta-hemolytic streptococcus {catalase (-)}. Most Neisseria sp. are catalase (+). Catalase can also help distinguish Bacillus sp. {catalase (+)} from Clostridum sp. {mostly catalase (-)}. SPECIMEN: Isolates preferably grown on non-blood containing media not older than 24 hours old. REAGENTS AND MATERIALS: 1. 3% hydrogen peroxide (from stock bottle). Store 2o – 25o C. Do not freeze or overheat. Light sensitive, store in brown bottle. 2. Clean microscope slide or glass test tube 3. Wooden applicator stick EQUIPMENT/INSTRUMENTATION: N/A QUALITY CONTROL: Each new lot and shipment or once a month, perform QC on reagent with stock organisms of S aureus (positive) and Beta strep group A (negative). -
Mass Spectrometry-Based Microbiological Testing for Blood
Nomura et al. Clin Proteom (2020) 17:14 https://doi.org/10.1186/s12014-020-09278-7 Clinical Proteomics REVIEW Open Access Mass spectrometry-based microbiological testing for blood stream infection Fumio Nomura1* , Sachio Tsuchida1, Syota Murata2, Mamoru Satoh1 and Kazuyuki Matsushita2 Abstract Background: The most successful application of mass spectrometry (MS) in laboratory medicine is identifcation (ID) of microorganisms using matrix-assisted laser desorption ionization–time of fight mass spectrometry (MALDI-TOF MS) in blood stream infection. We describe MALDI-TOF MS-based bacterial ID with particular emphasis on the methods so far developed to directly identify microorganisms from positive blood culture bottles with MALDI-TOF MS including our own protocols. We touch upon the increasing roles of Liquid chromatography (LC) coupled with tandem mass spectrometry (MS/MS) as well. Main body: Because blood culture bottles contain a variety of nonbacterial proteins that may interfere with analysis and interpretation, appropriate pretreatments are prerequisites for successful ID. Pretreatments include purifcation of bacterial pellets and short-term subcultures to form microcolonies prior to MALDI-TOF MS analysis. Three commercial protocols are currently available: the Sepsityper® kit (Bruker Daltonics), the Vitek MS blood culture kit (bioMerieux, Inc.), and the rapid BACpro® II kit (Nittobo Medical Co., Tokyo). Because these commercially available kits are costly and bacterial ID rates using these kits are not satisfactory, particularly for Gram-positive bacteria, various home-brew protocols have been developed: 1. Stepwise diferential sedimentation of blood cells and microorganisms, 2. Combi- nation of centrifugation and lysis procedures, 3. Lysis-vacuum fltration, and 4. Centrifugation and membrane fltra- tion technique (CMFT). -
Helicobacter Pylori Infections: Culture from Stomach Biopsy, Rapid Urease Test (Cutest®), and Histologic Examination of Gastric Biopsy
Available online at www.annclinlabsci.org 148 Annals of Clinical & Laboratory Science, vol. 45, no. 2, 2015 An Efficiency Comparison between Three Invasive Methods for the Diagnosis of Helicobacter pylori Infections: Culture from Stomach Biopsy, Rapid Urease Test (CUTest®), and Histologic Examination of Gastric Biopsy Avi Peretz1, Avi On 2, Anna Koifman1, Diana Brodsky1, Natlya Isakovich1, Tatyana Glyatman1, and Maya Paritsky3 1Clinical Microbiology Laboratory, 2Pediatric Gastrointestinal Unit, and 3Gastrointestinal Unit, Baruch Padeh Medical Center, Poria, affiliated to the Faculty of Medicine, Bar Ilan University, Galille, Israel Abstract. Background. Helicobacter pylori is one of the most prevalent pathogenic bacteria in the world, and humans are its principal reservoir. There are several available methods to diagnose H. pylori infection. Disagreement exists as to the best and most efficient method for diagnosis. Methods. In this paper, we report the results of a comparison between three invasive methods for H. pylori diagnosis among 193 pa- tients: culture, biopsy for histologic examination, and rapid urease test (CUTest®). Results. We found that all three methods have a high sensitivity and specificity for the diagnosis of infections caused by H. pylori. However, the culture method, which is not used routinely, also showed high sensitivity, probably due to biopsies’ seeding within 30 minutes, using warm culture media, non-selective media, and longer incuba- tion. Conclusions. Although not a routine test, culture from biopsy can be meaningful in identification of antibiotic-resistant strains of H. pylori and should therefore be considered a useful diagnostic tool. Keywords: Helicobacter pylor, Culture, Urease test, Gastric biopsy. Introduction Helicobacter pylori is one of the most prevalent Recently, a close association was found between H. -
Section 13. Laboratory Considerations
Section 13. Laboratory Considerations Table of Contents 13.1 Overview and General Guidance 13.2 Specimen Labeling 13.3 Procedures for Specimens That Cannot be Evaluated 13.4 Use of LDMS 13.5 Documentation 13.6 Urine Testing 13.6.1 Specimen Collection 13.6.2 Pregnancy Testing 13.6.3 Chlamydia and Gonorrhea Testing 13.6.4 Urine Culture 13.7 Blood Testing 13.7.1 Specimen Collection and Initial Processing 13.7.2 HIV Testing 13.7.3 Syphilis Testing 13.7.4 Hematology Testing 13.7.5 Serum Chemistries 13.7.6 Plasma Storage 13.7.7 CD4+ T Cell Count 13.7.8 HIV RNA PCR 13.7.9 HIV DNA PCR 13.8 Testing of Vaginal and Cervical Specimens 13.8.1 Vaginal pH 13.8.2 Wet Mount for Candidiasis and BV 13.8.3 Rapid Test for Trichomoniasis 13.8.4 Vaginal Gram Stain 13.8.5 Papanicolaou (Pap) Test 13.8.6 Self-Administered Vaginal Swabs for PK and biomarker testing 13.8.7 Endocervical Swabs for Biomarker Analysis 13.8.8 Intra-Vaginal Ring Storage 13.8.9 Herpes Lesion Testing Table 13-1 Volume Guide for Plasma Storage Appendix 13-1 Overview of Laboratory Testing Locations, Specimens, and Methods for MTN-020 Appendix 13-2 MTN-020 Lab Specimen Processing Guidelines Appendix 13-3 LDMS Specimen Management Guide to Logging in MTN-020 Specimens Appendix 13-4 MTN-020 HIV Testing Algorithms Appendix 13-5 MTN Network Lab HIV Query Form Appendix 13-6 LDMS Tracking Sheets This section contains information on the laboratory procedures performed in MTN-020. -
Use of the Diagnostic Bacteriology Laboratory: a Practical Review for the Clinician
148 Postgrad Med J 2001;77:148–156 REVIEWS Postgrad Med J: first published as 10.1136/pmj.77.905.148 on 1 March 2001. Downloaded from Use of the diagnostic bacteriology laboratory: a practical review for the clinician W J Steinbach, A K Shetty Lucile Salter Packard Children’s Hospital at EVective utilisation and understanding of the Stanford, Stanford Box 1: Gram stain technique University School of clinical bacteriology laboratory can greatly aid Medicine, 725 Welch in the diagnosis of infectious diseases. Al- (1) Air dry specimen and fix with Road, Palo Alto, though described more than a century ago, the methanol or heat. California, USA 94304, Gram stain remains the most frequently used (2) Add crystal violet stain. USA rapid diagnostic test, and in conjunction with W J Steinbach various biochemical tests is the cornerstone of (3) Rinse with water to wash unbound A K Shetty the clinical laboratory. First described by Dan- dye, add mordant (for example, iodine: 12 potassium iodide). Correspondence to: ish pathologist Christian Gram in 1884 and Dr Steinbach later slightly modified, the Gram stain easily (4) After waiting 30–60 seconds, rinse with [email protected] divides bacteria into two groups, Gram positive water. Submitted 27 March 2000 and Gram negative, on the basis of their cell (5) Add decolorising solvent (ethanol or Accepted 5 June 2000 wall and cell membrane permeability to acetone) to remove unbound dye. Growth on artificial medium Obligate intracellular (6) Counterstain with safranin. Chlamydia Legionella Gram positive bacteria stain blue Coxiella Ehrlichia Rickettsia (retained crystal violet). -
Gram Stain Workshop for the Laboratory Generalist
Gram Stain Workshop for the Laboratory Generalist Karen Stiles, SM(ASCP)CM State Training Coordinator Assistant Chemical Terrorism Coordinator Nebraska Public Health Laboratory 402-559-3590 [email protected] 1 GRAM STAIN OBJECTIVES: Upon completion, the participant will be able to: 1. Explain the principle of the Gram stain procedure, including what elements can affect staining results 2. Correlate the most common pathogens with positive Gram stains from blood cultures and direct specimen sterile body fluid smears 3. Perform and interpret Grams stains 2 Purpose of Gram Stain Classify bacteria based on form, size, cellular morphology, Gram reaction Assess quality of specimen Identify specific infectious agent from morphology and Gram reaction Correlation with culture growth Correlation with culture-independent methodologist Guide presumptive antibiotic therapy 3 Principle of Gram Stain Cell wall composition Gram positive – think peptidoglycan layer with teichoic acid Gram negative – high in lipid content Basic premise Crystal Violet – all cells take up primary stain Gram’s iodine – mordant to form complex Decolorizer – mixture of acetone and alcohol Dehydrate lipids in Gram negative cell walls, wash out complex Gram positive cells resistant, retain stain complex Safranin - counterstain 4 Gram negative cells take up counterstain Preparation of Samples Specimen Type Preparation CSF/sterile body fluids Cyto/Centrifuge Blood Culture Broth Drop to slide Tissue Touch prep Tissue homogenate Drop to slide Swabbed material Roll -
Syphilis Diagnosis: Three Cases with Increasing Treponemal Test Result After Therapy
Acta Derm Venereol 2014; 94: 323–324 SHORT COMMUNICATION Syphilis Diagnosis: Three Cases with Increasing Treponemal Test Result after Therapy Henrik O. Larsson1*, Annika Johnsson2 and Anders Bredberg1 Departments of 1Medical Microbiology, and 2Dermatology and Venereology, Skane University Hospital, Lund University, Jan Waldenströms gata 59, SE- 205 02 Malmö, Sweden. *E-mail: [email protected] Accepted May 4, 2013 Epub ahead of print Oct 3, 2013 Serology is a main tool for syphilis diagnostic work used (the Captia Syphilis-Enzywell Treponema IgG and IgM, (1–3). According to a recent survey performed by the respectively, EIA from Diesse, Monteriggioni, Italy); the IgG method uses antigen-coated wells and IgM is determined by U.S. Centers for Disease Control and Prevention (CDC) capture technique; a value over 1.0 is considered to be reactive 56% of infectious disease specialists responded that they (7). Particle agglutination was done at serum dilution 80 with send a rapid plasma reagin (RPR) test to the laboratory no quantitation of the result (TPPA, Fujirebio, Tokyo, Japan). and treat presumptively for syphilis (if result is negative 18% repeat the RPR testing before treating the patient, and 17% treat only if RPR is positive) (4). However, a RESULTS clearly positive reaction may be missing at the first visit Case 1 was tested twice, at 6 days before and 112 of patients with active syphilis (5). Non-treponemal test days after treatment start (Fig. 1, upper panel). The (e.g. RPR and Venereal Disease Research Laboratory treponemal screening value is rising from 4 to a highly (VDRL)) reactivity is known to decrease in response to reactive value of 14, while the non-treponemal VDRL therapy, in contrast to the typically life-long persistence titre decreases from a weak 1 to negativity. -
Medical Bacteriology
LECTURE NOTES Degree and Diploma Programs For Environmental Health Students Medical Bacteriology Abilo Tadesse, Meseret Alem University of Gondar In collaboration with the Ethiopia Public Health Training Initiative, The Carter Center, the Ethiopia Ministry of Health, and the Ethiopia Ministry of Education September 2006 Funded under USAID Cooperative Agreement No. 663-A-00-00-0358-00. Produced in collaboration with the Ethiopia Public Health Training Initiative, The Carter Center, the Ethiopia Ministry of Health, and the Ethiopia Ministry of Education. Important Guidelines for Printing and Photocopying Limited permission is granted free of charge to print or photocopy all pages of this publication for educational, not-for-profit use by health care workers, students or faculty. All copies must retain all author credits and copyright notices included in the original document. Under no circumstances is it permissible to sell or distribute on a commercial basis, or to claim authorship of, copies of material reproduced from this publication. ©2006 by Abilo Tadesse, Meseret Alem All rights reserved. Except as expressly provided above, no part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without written permission of the author or authors. This material is intended for educational use only by practicing health care workers or students and faculty in a health care field. PREFACE Text book on Medical Bacteriology for Medical Laboratory Technology students are not available as need, so this lecture note will alleviate the acute shortage of text books and reference materials on medical bacteriology. -
Diagnostic Microbiology 170-1 Provides an Overview of the Most Commonly Used Stains
PART Infectious Diseases XVII Section cells is used to judge the suitability of a specimen for culture. For 1 example, the presence of more than 10 epithelial cells per low-power field in a sputum specimen is highly suggestive of a specimen contami- General Considerations nated with oral secretions. In addition, a preliminary assessment of the etiologic agent can be made based upon the morphology (e.g., cocci vs rods) and stain reaction (e.g., Gram-positive isolates are purple; Gram- negative are red) of the microorganisms. However, a negative Gram stain does not rule out infection as 104 to 105 microorganisms per mL Chapter 170 in the specimen are required for detection by this method. In addition to the Gram stain, many other stains are used in micro- biology, both to detect organisms and to help infer their identity. Table Diagnostic Microbiology 170-1 provides an overview of the most commonly used stains. Carey-Ann D. Burnham and Isolation and Identification Gregory A. Storch The approach to isolation of microorganisms in a clinical specimen will vary depending on the body site and pathogen suspected. For body sites that are usually sterile, such as cerebrospinal fluid, nutrient-rich media such as sheep blood agar and chocolate agar are used to aid in Laboratory evidence to support the diagnosis of an infectious disease the recovery of fastidious pathogens. In contrast, stool specimens may be based on 1 or more of the following: direct examination of contain abundant amounts of commensal bacteria and thus to isolate specimens using microscopic or antigen detection techniques, isola- pathogens, selective and differential media must be used. -
Rapid Syphilis Testing Protocol Wisconsin Department of Health Services STD Control Program
Rapid Syphilis Testing Protocol Wisconsin Department of Health Services STD Control Program P-01832 June 2017 Table of Contents Bureau of Communicable Diseases (BCD) Staff Contact List ........................................................................ 3 Common Acronyms and Terms ..................................................................................................................... 4 Introduction and Background ....................................................................................................................... 5 Syphilis FAQ ................................................................................................................................................... 6 Rapid Syphilis Testing Algorithm ................................................................................................................... 9 Program Requirements ............................................................................................................................... 10 Agency Flow of Services .............................................................................................................................. 15 Rapid Syphilis Testing in Nontraditional or Outreach Settings ................................................................... 15 Syphilis Risk Assessment with Rapid Tests ................................................................................................. 17 Syphilis Health Check Testing Kit ............................................................................................................... -
Evaluation of a Highly Sensitive Method of Measuring Syphilis TP Antibody, and a New Approach to Syphilis Testing
Sysmex Journal International Vol. 22 No. 1 Evaluation of a Highly Sensitive Method of Measuring Syphilis TP Antibody, and a New Approach to Syphilis Testing Hiroshi SHIBATA, Hidehiko MORIYAMA, Yuki TANIGUCHI, Chikafumi MATSUDA and Atsushi NAGAI Central Clinical Laboratory, Shimane University Hospital 89-1 Enya, Izumo, Shimane, 693-8501 Japan. INTRODUCTION facilitates reaction between the sample (TP-Ab) and a biotinylated TP-Ag. In the next step, there is binding with Syphilis is a typical systemic sexually transmitted disease streptavidin-coated magnetic particles. Then, after that is caused by infection by Treponema pallidum (TP), bound/free (B/F) separation, the complex is further a pathogenic spirochete. Immunoserological tests with bound to ALP-labeled TP-Ag. After another B/F serum samples are generally used for testing TP separation, the chemiluminescent substrate CDP-Star is infection. These are typically TP antibody (TP-Ab) added and the intensity of luminescence measured. assays wherein a TP bacterial component is used as the We used VIRATROL (Sysmex) for examining the antigen, and serological test for syphilis (STS) that uses accuracy of the measurement, and an enzyme linked the phospholipid cardiolipin as the antigen. immunosorbent assay using TPauto·FS (KW) (ELSIA- In recent years, along with the advancement of testing TP; Sysmex) as the control for comparing the test results. methods, syphilis TP-Ab testing has been automated and Samples with disagreement of findings were investigated there have been considerable advances in improving through testing by TP hemagglutination assay (TPHA) sensitivity, speed and labor savings. We shall report here (Fujirebio Inc.), rapid plasma reagin (RPR) carbon the results of basic investigations on TP-Ab antigen test (Dainippon Sumitomo Pharma), and measurements using a recombinant TP antigen (TP-Ag) fluorescent Treponema antibody absorption test (FTA- and the automated immunoassay system HISCL-2000i ABS) (Nihon BCG Supply). -
Identification and Antimicrobial Susceptibility Testing of Anaerobic
antibiotics Review Identification and Antimicrobial Susceptibility Testing of Anaerobic Bacteria: Rubik’s Cube of Clinical Microbiology? Márió Gajdács 1,*, Gabriella Spengler 1 and Edit Urbán 2 1 Department of Medical Microbiology and Immunobiology, Faculty of Medicine, University of Szeged, 6720 Szeged, Hungary; [email protected] 2 Institute of Clinical Microbiology, Faculty of Medicine, University of Szeged, 6725 Szeged, Hungary; [email protected] * Correspondence: [email protected]; Tel.: +36-62-342-843 Academic Editor: Leonard Amaral Received: 28 September 2017; Accepted: 3 November 2017; Published: 7 November 2017 Abstract: Anaerobic bacteria have pivotal roles in the microbiota of humans and they are significant infectious agents involved in many pathological processes, both in immunocompetent and immunocompromised individuals. Their isolation, cultivation and correct identification differs significantly from the workup of aerobic species, although the use of new technologies (e.g., matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, whole genome sequencing) changed anaerobic diagnostics dramatically. In the past, antimicrobial susceptibility of these microorganisms showed predictable patterns and empirical therapy could be safely administered but recently a steady and clear increase in the resistance for several important drugs (β-lactams, clindamycin) has been observed worldwide. For this reason, antimicrobial susceptibility testing of anaerobic isolates for surveillance